Ajanta Pharma

Ajanta Pharma Ltd Nine Monthly Results

NSEBSE

₹2,706.1

(-2.16%)

Apr 30, 2025|03:50:43 PM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
Gross Sales	3,477.69	3,154.63	2,860.8	2,470.7	2,132.85
Excise Duty	0	0	0	0	0
Net Sales	3,477.69	3,154.63	2,860.8	2,470.7	2,132.85
Other Operating Income	0	0	0	0	0
Other Income	76.39	66.67	108.04	86.2	23.45
Total Income	3,554.08	3,221.3	2,968.84	2,556.9	2,156.3
Total Expenditure	2,515.34	2,278.58	2,273.15	1,748.09	1,393.7
PBIDT	1,038.74	942.72	695.69	808.81	762.6
Interest	14.66	5.68	4.71	2.86	5.71
PBDT	1,024.08	937.04	690.98	805.95	756.89
Depreciation	104.33	101.15	97.78	94.14	85.49
Minority Interest Before NP	0	0	0	0	0
Tax	250.34	248.95	140.25	156.06	178.04
Deferred Tax	-25.72	-26.51	-12.78	-5.72	-1.25
Reported Profit After Tax	695.13	613.45	465.73	561.47	494.61
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	695.13	613.45	465.73	561.47	494.61
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	695.13	613.45	465.73	561.47	494.61
EPS (Unit Curr.)	55.52	48.72	36.35	64.89	57.16
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	1,400	2,550	0	475	0
Equity	25.07	25.27	25.71	17.39	17.39
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	29.86	29.88	24.31	32.73	35.75
PBDTM(%)	29.44	29.7	24.15	32.62	35.48
PATM(%)	19.98	19.44	16.27	22.72	23.19

No Record Found

Invest wise with Expert advice